Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Version history
  • Article usage
  • Citations to this article

Advertisement

CorrigendumCell biology Free access | 10.1172/JCI25461C1

Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia

Charuhas V. Thakar, Kamyar Zahedi, Monica P. Revelo, Zhaohui Wang, Charles E. Burnham, Sharon Barone, Shannon Bevans, Alex B. Lentsch, Hamid Rabb, and Manoocher Soleimani

Find articles by Thakar, C. in: PubMed | Google Scholar

Find articles by Zahedi, K. in: PubMed | Google Scholar

Find articles by Revelo, M. in: PubMed | Google Scholar

Find articles by Wang, Z. in: PubMed | Google Scholar

Find articles by Burnham, C. in: PubMed | Google Scholar

Find articles by Barone, S. in: PubMed | Google Scholar

Find articles by Bevans, S. in: PubMed | Google Scholar

Find articles by Lentsch, A. in: PubMed | Google Scholar

Find articles by Rabb, H. in: PubMed | Google Scholar

Find articles by Soleimani, M. in: PubMed | Google Scholar

Published February 1, 2006 - More info

Published in Volume 116, Issue 2 on February 1, 2006
J Clin Invest. 2006;116(2):549–549. https://doi.org/10.1172/JCI25461C1.
© 2006 The American Society for Clinical Investigation
Published February 1, 2006 - Version history
View PDF

Related article:

Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia
Charuhas V. Thakar, … , Hamid Rabb, Manoocher Soleimani
Charuhas V. Thakar, … , Hamid Rabb, Manoocher Soleimani
Research Article Cell biology Article has an altmetric score of 6

Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia

  • Text
  • PDF
Abstract

Thrombospondin 1 (TSP-1) is a matricellular protein that inhibits angiogenesis and causes apoptosis in vivo and in vitro in several cancerous cells and tissues. Here we identify TSP-1 as the molecule with the highest induction level at 3 hours of IR injury in rat and mouse kidneys subjected to ischemia/reperfusion (IR) injury using the DNA microarray approach. Northern hybridizations demonstrated that TSP-1 expression was undetectable at baseline, induced at 3 and 12 hours, and returned to baseline levels at 48 hours of reperfusion. Immunocytochemical staining identified the injured proximal tubules as the predominant sites of expression of TSP-1 in IR injury and showed colocalization of TSP-1 with activated caspase-3. Addition of purified TSP-1 to normal kidney proximal tubule cells or cells subjected to ATP depletion in vitro induced injury as demonstrated by cytochrome c immunocytochemical staining and caspase-3 activity. The deleterious role of TSP-1 in ischemic kidney injury was demonstrated directly in TSP-1 null mice, which showed significant protection against IR injury–induced renal failure and tubular damage. We propose that TSP-1 is a novel regulator of ischemic damage in the kidney and may play an important role in the pathophysiology of ischemic kidney failure.

Authors

Charuhas V. Thakar, Kamyar Zahedi, Monica P. Revelo, Zhaohui Wang, Charles E. Burnham, Sharon Barone, Shannon Bevans, Alex B. Lentsch, Hamid Rabb, Manoocher Soleimani

×

Original citation: J Clin Invest. 2005;115(8):3451–3459. doi:10.1172/JCI25461.

Citation for this corrigendum: J Clin Invest. 2006;116(2):549. doi:10.1172/JCI25461C1.

Figure ​6B was incorrect in that the top panels were identical. The correct version of ​Figure6B follows.

Figure 6

The authors regret this error.

Version history
  • Version 1 (February 1, 2006): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 31 patents
74 readers on Mendeley
See more details